We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




IgG Assays Determine Serological Status to Measles/ Mumps Viruses

By LabMedica International staff writers
Posted on 09 Aug 2011
Two new assays were developed for the semi-quantitative determination of antibodies to measles and mumps viruses.

The Liaison Measles Immunoglobulin G (IgG) and Liaison Mumps IgG assays use chemiluminescence immunoassay technology on the Liaison analyzer for the semiquantitative determination of IgG antibodies to measles and mumps viruses in human serum or plasma.

The introduction of these assays by DiaSorin (Vercelli, Italy) completes the company's Liaison Measles, Mumps, Rubella, and Varicella Zoster (MMRV) IgG panel of assays, which are performed on a single platform. More...
DiaSorin’s Liaison IgG assays are fully automated semiquantitative or quantitative serology assays, each having a time-to-first result of 35 minutes and a throughput of 90 results per hour.

The Liaison analyzer combines a flexible operating mode with a broad assay menu and is very efficient due to its long walk-away time. The possibility to run up to 15 different assays at a time provides everyday testing even for low numbers of samples. A throughput of up to 180 determinations per hour allows the instrument to cope easily with a large number of samples. It is easy to use due to its touch-screen monitor, clear software structure, and the Reagent Integral, which contains all assay-specific reagents.

Related Links:

DiaSorin





New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated PCR System
OnePCR
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.